國家衛生研究院 NHRI:Item 3990099045/8458
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 907217      在线人数 : 899
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/8458


    题名: Recombinant bacille Calmette–Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis
    作者: Chen, YY;Lin, CW;Huang, WF;Chang, JR;Su, IJ;Hsu, CH;Cheng, HY;Hsu, SC;Dou, HY
    贡献者: Division of Infectious Diseases;Division of Vaccine Research and Development
    摘要: Background The tuberculosis (TB) pandemic continues to be a leading cause of human morbidity and mortality despite widespread use of the only licensed anti-TB vaccine, BCG. The protective efficacy of BCG in preventing pulmonary TB remains highly variable, so that an effective new vaccine is urgently required. Methods In the present study, we assessed the ability of novel recombinant BCG vaccine (rBCG) against Mycobacterium tuberculosis (MTB) by using modern immunological methods. Results ELISPOT assays demonstrated that rBCG vaccine co-expressing two mycobacterial antigens (Ag85B and CFP10) and human interleukin (IL)-12 (rBCG2) elicits greater interferon-γ (IFN-γ) release in mouse lung and spleen, compared to parental BCG. Also, rBCG2 is able to trigger a Th1-polarized response. Our results also showed that rBCG2 vaccination significantly limits M. tuberculosis H37Rv multiplication in macrophages. Surprisingly, rBCG2 was able to induce significantly higher tumor necrosis factor-α (TNF-α) production by peripheral blood mononuclear cells exposed to a non-mycobacterial stimulus, compared to parental BCG. Conclusion In this study, we demonstrated that the novel rBCG2 vaccine might be a promising candidate vaccine against MTB infection.
    日期: 2017-01
    關聯: Journal of Microbiology, Immunology and Infection. 2017 Feb;50(1):90-96.
    Link to: http://dx.doi.org/10.1016/j.jmii.2014.11.019
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1684-1182&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000396932000014
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84923630435
    显示于类别:[杜鴻運] 期刊論文
    [蘇益仁(2002-2015)] 期刊論文
    [許素菁] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    SDO1684118214002503.pdf1342KbAdobe PDF714检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈